214 results on '"Potus, François"'
Search Results
2. The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets
3. Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension
4. A HIF-2α-dependent KMT2E-AS1/KMT2E axis orchestrates endothelial epigenetic and metabolic dysfunction in pulmonary hypertension
5. PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
6. ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming
7. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis
8. MicroRNA targeted therapy in cardiovascular disease
9. List of contributors
10. HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
11. Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
12. Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
13. Right Ventricle and Epigenetics: A Systematic Review
14. Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
15. Role of histone acetyltransferases P300/CBP in pulmonary arterial hypertension and right heart failure
16. Identification of AURKB as a new actor in vascular remodeling in PAH
17. The Fibronectin-Binding Integrins System as a Contributor to PAH Pathogenesis
18. Targeting DHPS-mediated hypusination of eIF5A improves vascular remodeling in PAH
19. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension
20. Skeletal Muscle Structural and Functional Impairments as Important Peripheral Exercise Intolerance Determinants in Pulmonary Arterial Hypertension.
21. Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension
22. microRNA and Pulmonary Hypertension
23. G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
24. Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease
25. Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction
26. DNA–Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension
27. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications
28. Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series)
29. Abstract 19042: Role for Leptin Signaling in Experimental Group 2 Pulmonary Hypertension Due to Metabolic Syndrome
30. BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial
31. Signal transduction in the development of pulmonary arterial hypertension
32. Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension
33. Neutrophil-Lymphocyte Ratio as an Independent Predictor of Survival in Pulmonary Arterial Hypertension: An Exploratory Study
34. Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra‐coronary aortic banding
35. Commentary on: Xbp1s-Ddit3, DNA damage and pulmonary hypertension
36. Sirtuin 3 and Uncouplin Protein 2, the Missing Link Between Genetics, Metabolism, and Pulmonary Arterial Hypertension
37. Abstract 10717: Role of Integrin Signaling in Pulmonary Arterial Hypertension
38. Abstract 12681: Implication of Aurora Kinase B in Pulmonary Arterial Hypertension
39. Abstract 10742: Implication of the Importins KPNA2 and KPNB1 in Pulmonary Arterial Hypertension
40. Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension
41. Pulmonary hypertension thresholds: time to lower further?
42. Impaired Angiogenesis and Peripheral Muscle Microcirculation Loss Contribute to Exercise Intolerance in Pulmonary Arterial Hypertension
43. Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
44. Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
45. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
46. R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models
47. Limitations and Flaws of Preclinical Pulmonary Hypertension Studies
48. Novel insights on the pulmonary vascular consequences of COVID-19
49. COVID-19 and the pulmonary vasculature
50. Supra‐coronary aortic banding improves right ventricular function in experimental pulmonary arterial hypertension in rats by increasing systolic right coronary artery perfusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.